Xencor (XNCR) Stock Analysis & AI Equity Report
Xencor (XNCR) overview
Xencor (XNCR) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 126m and operating profit of USD -178m; the year-end share price was 15.31 USD and market capitalisation was USD 1,100m. Xencor is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Xencor's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
About Xencor
Xencor is a clinical-stage biopharmaceutical company that discovers and develops engineered antibody therapeutics for cancer and autoimmune diseases. Its protein engineering technologies support XmAb drug candidates with features such as multi-target activity, bispecific structures, and extended half-life. The company advances candidates through clinical development and may develop programs with partners. Its research portfolio includes T-cell engaging antibodies and candidates for solid tumors and autoimmune conditions.
Generate the Xencor report
Xencor is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Xencor and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.
Analyst reports on Xencor
Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.